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Infection and inflammation are well recognized causes of spontaneous preterm
delivery (PTD) (<37 gestational weeks) and adverse infant outcomes. To date, there
has been very little investigation into bacterial communities in amniotic fluid using
next generation sequencing technology. In particular, it is important to characterize
amniotic fluid bacterial profiles in complicated pregnancies as well as in asymptomatic
women to identify predictive bacterial DNA signatures. Here, 1198 mid-trimester
amniotic fluid samples from a cohort of Swedish women undergoing mid-trimester
genetic amniocentesis were screened for bacterial DNA using qPCR protocols
specifically designed to reduce the impacts of reagent contamination and human
DNA mispriming. The majority of samples were devoid of detectable bacterial DNA;
however, approximately a fifth of the cohort (19.9%) were 16S rRNA gene positive
in duplicate screening. Among these, nine women had a spontaneous PTD. These
nine women were matched with 18 healthy women with a delivery at term. We used
PacBio SMRT technology, coupled with appropriate negative extraction and PCR
controls, to sequence the full-length 16S rRNA gene in this subset of 27 women.
The amniotic fluid samples contained low-abundance and low-diversity bacterial DNA
profiles. Species typically associated with spontaneous PTD were absent. We were not
able to identify any differences in the amniotic fluid bacterial DNA profiles of women
with a subsequent spontaneous PTD compared to women who delivered at term. The
findings suggest that, in a minor proportion of pregnancies, DNA from non-pathogenic
bacteria may be present in the amniotic fluid far earlier than previously reported. Early
detection of bacterial DNA in the amniotic fluid was, in this study, not associated with
spontaneous PTD.
Keywords: amniotic fluid, bacteria, 16S rRNA, preterm birth, microbial invasion of amniotic cavity
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BACKGROUND
The existence of a fetal or in utero microbiome (an ecosystem
of interacting microorganisms) in normal pregnancy remains
controversial (Collado et al., 2016; Stinson et al., 2016; de
Goffau et al., 2019). Numerous studies have investigated
bacterial colonization of the amniotic fluid in both complicated
and healthy pregnancies using culture-dependant and culture-
independent techniques. These studies have reported a diverse
range of results, with some finding that amniotic fluid was
devoid of bacteria (Rowlands et al., 2017), some finding that
all amniotic fluid samples contain bacteria (Collado et al.,
2016; Urushiyama et al., 2017; Wang et al., 2018; Zhu et al.,
2018), and yet others reporting a combination of positive and
negative samples (Watts et al., 1992; Mandar et al., 2001;
Bearfield et al., 2002; Mendz et al., 2013; Cobo et al., 2017;
Kayem et al., 2018; Lim et al., 2018; Morimoto et al., 2018;
Stinson et al., 2019a). While pathogenic colonization of the
amniotic fluid has been well-documented and thoroughly studied
in the context of spontaneous preterm delivery (PTD; <37
gestational weeks) and fetal infection (DiGiulio, 2012; Mendz
et al., 2013; Stinson and Payne, 2019; Thorell et al., 2019),
little is known about the nature, origins, and significance of
any endemic amniotic fluid bacteria in normal pregnancies. In
particular, the timing and stability of such colonization remains
largely unexplored. Such information is important, as bacterial
populations in the amniotic fluid are likely to influence fetal
skin and gut colonization (via swallowing of the amniotic fluid
which begins at the end of the first trimester) which could have
important implications for the development and maturation of
the fetal immune system.
To date, there has been limited characterization of bacterial
populations in amniotic fluid from uncomplicated pregnancies
using next generation sequencing (Collado et al., 2016;
Urushiyama et al., 2017; Kayem et al., 2018; Lim et al.,
2018; Wang et al., 2018; Zhu et al., 2018; Stinson et al.,
2019a). Unfortunately, most previous studies are complicated
by the fact that appropriate and stringent extraction and
PCR controls were not used. None of these studies attempted
to eliminate reagent-derived contamination using laboratory-
based techniques, such as those previously described by our
group (Stinson et al., 2018). This makes it difficult to make
conclusions on the true level of bacterial DNA in their samples.
Apart from being inadequately controlled, these studies have
all relied on short 16S rRNA gene amplicons with different
variable regions for their sequencing. While such an approach is
somewhat useful for broad community profiling without detailed
taxonomic information, it is not able to give accurate species
level assignment (Martinez-Porchas et al., 2016). Additionally,
the selection of the region of the 16S rRNA gene to be
sequenced can introduce bias into the results (Cruaud et al.,
2014; Tremblay et al., 2015). Furthermore, some of these studies
used QIIME v1 for operational taxonomic unit (OTU) clustering
and taxonomic assignment, a platform which has been shown
to give inaccurate taxonomic assignments and to inflate the
number of OTUs in a sample when the default settings are used
(Edgar, 2017).
The existence of an amniotic fluid microbiome is contentious;
however, there is some evidence to suggest that bacterial DNA
is commonly found in amniotic fluid at delivery (Collado et al.,
2016; Urushiyama et al., 2017; Wang et al., 2018; Stinson
et al., 2019a). It is not known when in gestation bacteria may
first be able to access the amniotic space. Apart from three
16S rRNA gene sequencing studies (Urushiyama et al., 2017;
Kayem et al., 2018; Zhu et al., 2018), studies of microbial
profiles in mid-trimester amniotic fluid to date have largely
relied on bacterial culture and targeted real-time PCR, and have
primarily focused on identifying pathogenic bacteria involved in
the etiology of spontaneous PTD (Watts et al., 1992; Bearfield
et al., 2002; Payne et al., 2014; Rowlands et al., 2017; Morimoto
et al., 2018). High quality data on the full microbial ecology
of mid-trimester amniotic fluid is lacking, making it difficult
to speculate on the extent to which bacterial DNA is found in
amniotic fluid at this time point. Importantly, by comparing
bacterial profiles in amniotic fluid samples from women with
a spontaneous PTD and those with a term delivery, we may
be able to identify a predictive microbiome signature of high-
risk pregnancies.
There is currently a need for robust, well-controlled studies
of the bacterial content of amniotic fluid in normal and high-
risk pregnancies, particularly one which employs full-length 16S
rRNA gene sequencing and appropriate measures to reduce
external contamination so that low biomass microbiota can be
described with confidence. In the present study, we characterized
the bacterial DNA profiles of amniotic fluid collected during mid-
trimester genetic amniocentesis from women with no clinical
evidence of infection that went on to deliver at term or by
spontaneous PTD.
MATERIALS AND METHODS
Cohort Selection
Between September 2008 and July 2017, 3126 women underwent
a mid-trimester genetic amniocentesis at Sahlgrenska University
Hospital/Östra, Gothenburg, Sweden (Figure 1). Amniocentesis
was performed per clinical indications such as advanced maternal
age, anxiety, abnormal first-trimester combined screening or
family history of chromosomal abnormalities or genetic diseases.
Women ≥18 years of age with a viable singleton pregnancy were
eligible. Women with multiple pregnancy, infectious diseases
(such as HIV or hepatitis B), who had known or suspected
fetal malformations as well as women undergoing amniocentesis
during times when study samples could not be collected
were considered ineligible (n = 763). Women who declined
participation, who had language difficulties and therefore could
not provide informed consent in Swedish, or if an insufficient
amount of fluid was retrieved during amniocentesis, were
considered excluded (n = 1148). The remaining 1215 women
were enrolled into the study. 16S rRNA gene data was retrieved
from 1198 women, of which 238 women tested positive in
the qPCR screen. Among these, nine healthy women had a
spontaneous PTD and they were matched with women who
delivered in gestational weeks 38+0 to 41+6 to a 1:2 ratio using
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FIGURE 1 | Flow chart of the cohort and selection of cases and controls.
the immediately preceding and following women in the cohort
(Figure 1), according to the following criteria:
1. Parity (primiparous or multiparous),
2. BMI (matched according to WHO definitions of BMI
categories: underweight (<18.5); normal weight (18.5–
24.9); pre-obesity (25.0–29.9); and obesity class I–III
(≥30.0),
3. Smoking (yes/no),
4. IVF (yes/no),
5. Ethnicity [categorized according to Burchard et al. (2003):
Black or African American (Africans); White (Caucasians);
and Asian].
Sample Collection
Three milliliter of amniotic fluid was collected for research
purposes (in addition to that collected for diagnostic use)
during mid-trimester genetic amniocentesis performed at 14–
20 gestational weeks at Sahlgrenska University Hospital/Östra,
Gothenburg, Sweden. Amniotic fluid samples were immediately
stored at 4–8◦C. The samples were centrifuged at 12,000 × g for
20 min at 4◦C to pellet the cells. Pellets were resuspended in 1 mL
sterile 1× PBS and frozen at −80◦C until processing. Samples
were initially shipped on dry ice to the Institute of Molecular
Biomedicine, Comenius University, Bratislava, Slovakia, where
200µL of cell pellet resuspension from each sample was aspirated
under aseptic conditions for downstream analyses unrelated to
the current study. These samples were again frozen at −80◦C
and shipped on dry ice to the Division of Obstetrics and
Gynaecology, The University of Western Australia, Crawley,
WA, Australia, for microbial profiling analyses used in the
current study. Other samples were sent directly (on dry ice) to
the Division of Obstetrics and Gynaecology, The University of
Western Australia, Crawley, WA, Australia from Gothenburg,
Sweden. These had thus not been thawed. There was no difference
in the downstream 16S rRNA gene qPCR results between the
samples that were shipped initially to Slovakia and those that were
shipped directly to Australia.
DNA Extraction
Amniotic fluid suspensions were centrifuged at 40,000 × g for
5 min at 4◦C to pellet cells. Cell pellets were resuspended in
353 µL Buffer MBL/RNase A solution (QIAGEN) and DNA was
extracted using a QIAGEN MagAttract Microbial DNA Kit on the
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KingFisher Flex platform as per manufacturer’s instructions. One
blank extraction control (EC) was included in the center of each
96 deep-well plate.
qPCR Screening
The 1198 samples were screened for bacterial DNA using a
custom Taqman qPCR protocol, adapted from Yang et al. (2002)
with a new forward primer to improve coverage of Ureaplasma
spp. and Mycoplasma spp. The V6 region of the 16S rRNA gene
was amplified in 20 µL reactions containing 6 µL of template or
water (negative template control), 1× TaqMan Fast Advanced
Master Mix (Applied Biosystems), 0.9 µM each of the forward
(917F 5′-GAATTGACGGGGRCCCGC-3′) and reverse (1033R
5′-TGCGGGACTTAACCCAACA-3′) primers, 0.25µM of probe
(5′-FAM-CACGAGCTGACGACARCCATGCA-TAMRA-3′),
and 0.95 µL of water. Master mix solutions were treated with
a PCR Decontamination Kit (ArcticZymes R©), which consisted
of a double-stranded DNase (dsDNase) and DTT (which helps
to inactivate the dsDNase), as previously described (Stinson
et al., 2018). Briefly, master mix solutions (including primers
and probes) were treated with 0.5 µl of dsDNase and 0.5 µl
of DTT per 20 µl reaction, then incubated at 37◦C for 20 min
(dsDNase activation), followed by incubation at 60◦C for 20 min
(dsDNase inactivation). This treatment eliminated amplification
of background microbial DNA, preventing negative template
controls from reading as positive, and allowing positive/negative
calls to be made confidently. Each qPCR was run with three
negative template controls and a 1 ng human DNA control
(which reflected the average total DNA assay input per sample –
combined microbial and human), as human DNA is a known
confounder in low biomass 16S rRNA gene studies due to
16S rRNA gene primers/probes binding to human gDNA with
varying affinity (Kommedal et al., 2012). For a sample to be
called positive, it had to have a cycle threshold (Ct) value at least
1 cycle less than the 1 ng human DNA control that was included
on the respective run. Utilizing this conservative approach, we
were able to account for mis-priming with human DNA on a
run-by-run basis. Samples were screened in duplicate to confirm
the findings, and only samples that produced positive results for
both replicates were considered positive. All samples were run
on a ViiA7 real-time PCR system (Life Technologies).
Ureaplasma Screening
Samples that tested positive for bacterial DNA by 16S rRNA gene
qPCR (n = 238) were further screened for Ureaplasma parvum
and Ureaplasma urealyticum DNA. Reactions consisted of 6 µl
of template or water (negative template control), 1× TaqMan
Fast Advanced Master Mix (Applied Biosystems), 0.9 µM of each
of the forward (5′-AAGGTCAAGGTATGGAAGATCCAA-3′)
and reverse (5′-TTCCTGTTGCCCCTCAGTCT-3′) primers,
0.25µM of the U. parvum and U. urealyticum probes (UU-parvo:
5′-FAM-TCCACAAGCTCCAGCAGCAATTTG-BHQ1-3′ and
UU-T960: 5′-VIC-ACCACAAGCACCTGCTACGATTTGTTC-
BHQ1-3′), and water to a final volume of 20 µL. Positive controls
consisting of purified U. parvum and U. urealyticum DNA were
included in each batch.
Amplification and Barcoding
Amniotic fluid samples from nine women with subsequent
spontaneous PTD and 18 matched controls with a delivery at
term (all of which were positive for bacterial DNA by qPCR
screen) were selected for full-length 16S rRNA gene sequencing.
The primers 27F (5′-gcagtcgaacatgtagctgactcaggtcacAGRGTTY
GATYMTGGCTCAG-3′) and 1492R (5′-tggatcacttgtgcaagcat
cacatcgtagRGYTACCTTGTTACGACTT-3′) were used, with
universal UNITAG sequences (in lower case) and a 5′ amine
(NH4-C6) block attached to each primer. A set of three
barcoded UNITAG-F and 15 barcoded UNITAG-R primers were
designed to generate PacBio sequencing-ready amplicons, using
an asymmetric barcoding strategy. All primers were synthesized
and HPLC-purified by Integrated DNA Technologies.
To obtain barcoded 16S rRNA gene amplicons, amplification
was carried out in two steps. The first PCR was carried
out in 50 µL reactions containing 7.5 µL of template or
water (negative template control), 1× AccuStart II ToughMix
(Quantabio), 0.3 µM each of the forward and reverse primers,
1.25 µL each of the ArcticZymes dsDNase and DTT, and
13.5 µL of water. The PCR amplification program consisted
of an initial heating step at 94◦C for 3 min; 40 cycles of
94◦C for 30 s, 55◦C for 30 s, and 72◦C for 2 min; and a
final extension step of 72◦C for 7 min. PCR reactions were
performed in a Veriti Thermal Cycler (Applied Biosystems).
PCR products were visualized on a QIAXcel automated
electrophoresis system using a DNA high resolution gel
cartridge (run parameters OM500) to confirm the presence and
size of amplicons.
Primary PCR products were purified using NucleoMag NGS
magnetic beads (Macherey-Nagel), normalized to 1 ng/µL, then
used as template in a secondary, nested PCR, in order to generate
asymmetrically barcoded amplicons. Secondary PCR was carried
out in 25 µL reactions containing 2 µL of template or water
(negative template control), 1× AccuStart II ToughMix, 0.3 µM
each of the forward and reverse primers, and 3 µL of water. The
PCR amplification program consisted of an initial heating step at
94◦C for 3 min; 10 cycles of 94◦C for 30 s, 55◦C for 30 s, and 72◦C
for 2 min; and a final extension step of 72◦C for 7 min.
PacBio Sequencing
Barcoded 16S rRNA gene amplicons obtained from the secondary
PCR were pooled in equimolar concentrations based on QIAXcel
quantitation of the target band. The pool was then concentrated
using NucleoMag NGS magnetic beads and eluted in 50 µL
of 1× TE. The pool was next visualized in a 1.2% agarose
gel using SYBR Safe DNA stain (Invitrogen) and bands of the
appropriate size were excised using a sterile disposable scalpel.
Excised bands were purified using a QIAquick Gel Extraction
Kit as per manufacturer’s instructions. 500 ng of purified DNA
was used for library preparation at the Ramaciotti Centre for
Genomics, University of NSW, Sydney, NSW, Australia. Here,
SMRTbell adapters were ligated onto barcoded PCR products,
and the library was sequenced on a PacBio Sequel system on
a single SMRT cell. Sequence files were deposited to NCBI
Sequence Read Archive under accession number PRJNA602788.
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Sequence Data Analysis
PacBio raw reads were processed using the SMRT Link Analysis
software version 6.0 to obtain demultiplexed circular consensus
sequence (CCS) reads with a minimum of three full passes
and 99.9% sequence accuracy. Sequence data were processed
using the software package GHAP v2.1. GHAP is an in-house
amplicon processing pipeline developed by Paul Greenfield
(CSIRO, Australia) (Greenfield, 2017) built around tools from
USearch (Edgar, 2010) and The Ribosomal Database Project
(RDP) (Cole et al., 2014), combined with locally written tools
for generating OTU tables. BIOM files (McDonald et al., 2012)
generated by GHAP were analyzed using MicrobiomeAnalyst –
a web-based tool for statistical and visual analysis of microbiome
data (Dhariwal et al., 2017). Reads were initially denoised using
GHAP with a minimum number of three reads in a minimum
of two samples required to retain an OTU. Alpha diversity
was assessed as number of observed OTUs and Chao1 (species
level analysis). Beta diversity was assessed using PERMANOVA
and unweighted unifrac distances. Differential abundance was
calculated univariately. All p-values were calculated using
student’s t-test unless stated otherwise.
Data Analysis
All qPCR data were analyzed using QuantStudioTM Real-Time
PCR Software, version 3.1 (Thermo Fisher Scientific) using
default settings (including both threshold and baseline set to
AUTO) to generate Ct values. Differences between characteristics
of subjects with positive or negative 16S rRNA gene results
and differences between cases and controls were analyzed with
Mann–Whitney U test for continuous variables, due to non-
parametric distribution of the variables, and with χ2 test or
Fishers exact test (if the expected value in any cell were 5 or less)
for dichotomous variables. Analyses were performed with IBM
SPSS Statistics, version 25).
RESULTS AND DISCUSSION
Maternal and Neonatal Characteristics
The medical and demographic details of the women being
screened for bacterial DNA are presented in Table 1. Cases of
missing data reflect women being lost to follow-up, women who
had an abortion or miscarriage, and women who were excluded
post-enrollment.
Bacterial DNA Is Present in Amniotic
Fluid in Mid-Pregnancy
Of the 1198 mid-trimester amniotic fluid samples screened
by qPCR, 238 (19.9%) contained detectable levels of bacterial
DNA. Each of these samples was confirmed as positive for
bacterial DNA in duplicate screening. Pregnancy demographic
characteristics for 16S rRNA gene positive (n = 238) and negative
(n = 960) samples are presented in Table 2, with no significant
differences between the groups. As in Table 1, missing data is due
to lost to follow-up, women with an abortion or miscarriage and
women who were excluded post-enrollment. Although bacterial
TABLE 1 | Pregnancy demographic characteristics of the cohort (n = 1198).
Characteristic Data available for n Mean (range) or n (%)
Maternal age (y) 1198 36.4 (20–47)
Nulliparity 1194 319 (27%)
Preterm delivery 1159 78 (7%)
GA at delivery (weekday) 1159 39+4 (22+1–43+0)
GA at sampling (weekday) 1193 15+6 (13+6–22+1)
BMI at first prenatal visit 1171 24.5 (15.8–47.4)
Smoking at first prenatal visit 1189 62 (5.2%)
Diabetes type 2 1198 4 (0.33%)
Gestational diabetes 1198 15 (1.3%)
Male/female fetus ratio 1160 592/606 (49.4/50.6%)
Values are reported as mean (range) or n (percent).
load was not quantified in this study, previous reports suggest
that amniotic fluid contains 100–1000 16S rDNA copies/mL
(Urushiyama et al., 2017; Lim et al., 2018). Considering that there
is substantial 16S rRNA gene copy number variation within the
genomes of different bacterial species however, these estimates
do not correlate with CFU/mL and actual bacterial cell numbers
may be as low as 1/15th of these values, depending on the
bacterial species present (Kembel et al., 2012). Regardless, these
data emphasize the low biomass nature of this sample type. In
the present study, the average Ct value for the 16S rRNA gene
positive samples was 34.1 (range: 28.5–43.9). Using a previously
described enzymatic decontamination protocol (Stinson et al.,
2018), we were able to produce completely negative extraction
and PCR controls in our qPCR screen, and this, combined
with the use of a biologically relevant (in terms of quantity)
human DNA control with each run to account for any potential
mis-priming, allowed us to make positive/negative calls with
a higher level of sensitivity and accuracy. It should be noted
that we did not collect negative controls during sampling, and
so we are not able to assess the possibility of contamination
during sample collection and initial processing, a limitation
that is common in most microbiome studies. However, the
absence of detectable bacterial DNA in the majority of samples
suggests that our sample collection protocol did not introduce
ubiquitous contamination.
We are not the first to screen amniotic fluid samples from mid-
trimester using universal 16S rRNA gene primers. Two previous
such studies have reported that 0 and 3% of samples were positive
for bacterial DNA (Rowlands et al., 2017; Kayem et al., 2018).
Neither of these studies, however, reported any details of controls
used and in the case of Rowlands et al. (2017), who used a qPCR
assay, it is unclear if samples were truly negative or if Ct cut-
off value for a negative result was set based upon amplification
present in negative PCR controls (a common practice used
for distinguishing “positive” samples from background noise).
Without the use of decontaminated reagents, negative controls
frequently appear at Cts similar to those of amniotic fluid in 16S
rRNA gene qPCR screening tests, making it incredibly difficult to
determine a true positive result.
Interestingly, our detection of bacterial DNA in the amniotic
fluid was not associated with spontaneous PTD. Only 14 of
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TABLE 2 | Pregnancy demographic characteristics for 16S rRNA gene positive
(n = 238) and negative (n = 960) samples.
Characteristic n Positive Negative p-Value
Maternal age (y) 1198 37 (21–46) 37 (20–47) 0.90
Nulliparity 1194 65 (27%) 254 (27%) 0.81
Preterm delivery 1159 64 (7%) 14 (6%) 0.68
GA at delivery
(week+day)
1159 39+4 (30+5–43+0) 39+3 (22+1–43+0) 0.36
GA at sampling
(week+day)
1193 15+6 (14+2–20+4) 15+6 (13+6–22+1) 0.47
BMI at first prenatal
visit
1171 23.1 (16.9–45.4) 23.6 (15.8–47.4) 0.18
Smoking at first
prenatal visit
1189 15 (6%) 47 (5%) 0.38
Diabetes type 2 1198 4 (0.4%) 0 (0)% 1.0
Gestational
diabetes
1198 1 (0.%) 14 (1.5%) 0.33
Male/female fetus
ratio
1160 111/118 (48.5/51.5%) 481/450 (51.7/48.3%) 0.39
Values are reported as mean (range) or n (percent).
TABLE 3 | Pregnancy demographic characteristics for cases (spontaneous
preterm delivery (<37 gestational weeks; n = 9) and controls (delivery at term;
n = 18).
Characteristic Cases (n = 9) Controls (n = 18) p-Value
Maternal age (y) 36 (21–43) 36 (23–44) 0.94
Nulliparitya 2 (22%) 4 (22%) 1.00
GA at delivery (week+day) 34+6 (30+5–36+6) 39+3 (37+1–42+1) < 0.001
GA at sampling (week+day) 15+4 (14+4–16+5) 15+5 (14+2–16+5) 0.78
Pre-pregnancy BMIa 24 (21–27) 24 (19–29) 0.78
Smoking during pregnancya 0 (0%) 0 (0%) –
IVFa 1 (11%) 2 (22%) 1.00
Diabetes type 2 0 (0%) 0 (0%) –
Gestational diabetes 0 (0%) 0 (0%) –
Male/female fetus ratio 4/5 (44/56%) 7/11 (39/61%) 1.00
Values are reported as mean (range) or n (percent). aMatching criteria.
the 238 positive samples (6.1%) were from women with a
spontaneous PTD, four of which were iatrogenic (medically
indicated) PTD. Of the samples that tested negative for bacterial
DNA, 6.9% were from women with a spontaneous PTD. There
was also no difference in the average gestational age at sampling
for those that tested positive for bacterial DNA compared to those
that tested negative (p = 0.47). Our data indicate that in some
pregnancies, bacterial DNA is present in the amniotic fluid at
14–20 weeks gestation. However, in the majority of cases, the
amniotic fluid appears sterile at this gestational age. Presence of
bacterial DNA in the amniotic cavity at mid-trimester did not
predict spontaneous PTD in our cohort.
Demographic details of the cases and controls which were
selected for bacterial profiling are presented in Table 3. There
were no significant differences between the groups.
The potential exposure of the fetus to bacteria at this early
gestational age is of particular interest, as the fetal skin does
not keratinize until approximately 20 weeks gestation (Wiberg-
Itzel, 2012). Prior to this stage, the fetal skin offers no resistance
to movement of the amniotic fluid, which can be thought of
as an extension of the fetal extra-cellular fluid. After fetal skin
keratinization occurs, the amniotic fluid changes in osmolality
and can no longer equilibrate with the fetus. The effect that
fetal skin keratinization has on the amniotic fluid microbiome
is unknown. The samples examined in the present study were
primarily taken prior to gestational week 20. The fetal skin
would not have acted as an effective barrier between the
amniotic fluid microbiome and the fetal extracellular fluid at this
stage in development.
Ureaplasma spp. Were Not Detected in
Mid-Trimester Amniotic Fluid Samples
Ureaplasma parvum and Ureaplasma urealyticum infection of
the intra-amniotic cavity is typically associated with spontaneous
PTD (Gray et al., 1992; Cassell et al., 1993; Horowitz et al.,
1995). Therefore, all samples that tested positive for bacterial
DNA by 16S rRNA gene qPCR (using primers optimized to
improve coverage of Ureaplasma spp.) were further screened for
U. parvum and U. urealyticum DNA using targeted qPCR (Yi
et al., 2005). All of these were found to be negative. Further, no
members of the Ureaplasma genus were identified by 16S rRNA
gene sequencing. These results are similar to those reported
by Payne et al. (2014) and Rowlands et al. (2017), both of
whom failed to detect Ureaplasma spp. DNA in mid-trimester
amniotic fluid from Australian women. Payne et al. (2014),
however, did detect Ureaplasma spp. DNA in two women (0.42%)
from their Chinese cohort. In contrast, Kayem et al. (2018)
screened 980 amniotic fluid samples taken for genetic testing
at 16–20 weeks gestation and reported that 12 samples (1.22%)
were positive for Ureaplasma spp. DNA (10 U. urealyticum and
2 U. parvum) by qPCR screening. Collectively the evidence
suggests that Ureaplasma spp. colonization of the amniotic cavity
in mid-gestation is a rare event.
Description of Bacterial DNA Profiles in
Mid-Trimester Amniotic Fluid
Overall, the amniotic fluid samples profiled here contained
low-abundance and low-diversity bacterial DNA profiles, as
was expected based on previous studies (Collado et al., 2016;
Urushiyama et al., 2017; Lim et al., 2018; Wang et al., 2018;
Figure 2). Of the 27 amniotic fluid samples sequenced, five (one
case and four controls) returned insufficient reads (≤50). Each
of these samples gave a clear positive signal on the qPCR screen,
but failed to produce an amplicon with the full-length 16S rRNA
gene primers used for sequencing, suggesting that the bacterial
DNA present in these samples were not covered by these primers.
This raises the possibility that the full breadth of the amniotic
fluid bacterial communities present were not captured in this
study. Of the remaining samples, we recovered an average of 6503
reads per sample (range 1284–9563) and 12 OTUs per sample
(range 2–33). Here, our negative PCR controls were completely
negative, while our negative ECs were sporadically positive. Seven
taxa were detected in six ECs: Pelomonas puraquae, Casaltella
massiliensis, Staphylococcus pasteuri, Bosea eneae, Bosea vestrisii,
Acinetobacter beijerinckii, and Rhodobacter blasticus (Table 4).
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However, in cases where one of these OTUs was detected in an
EC, it was not detected in the samples that were extracted in that
batch, suggesting that extraction-based contamination was not a
contributor to our results.
At the species level, amniotic fluid samples were dominated
by reads that mapped to Saccharibacteria (TM7 oral clone),
Acidovorax temperans, Tepidimonas taiwanensis, and P. puraquae
(Figure 3). Eleven samples contained reads that mapped to
Saccharibacteria (TM7 human oral clone), an extremely small
coccus (200–300 nm) that until recently has been uncultivated,
but is ubiquitous in numerous environments (He et al.,
2015). It is important to note that Saccharibacteria was not
a particularly good match for this particular OTU, with only
92.6–93% sequence homology. This might indicate that these
OTUs belong not to Saccharibacteria, but to a related, as-yet
undescribed bacteria (for example, an uncultivated clade of
FIGURE 2 | Abundance (number of reads) of bacterial species detected in mid-trimester amniotic fluid samples from women with spontaneous preterm delivery
(cases, n = 9) and women with a delivery at term (matched controls, n = 18).
TABLE 4 | Bacterial taxa (number of reads) detected in negative extraction controls (EC) and negative PCR controls (NTC, no template controls).
Species EC1 EC2 EC5 EC6 EC7 EC8 EC10 EC11 NTC1 NTC2
Casaltella massiliensis 10170
Pelomonas puraquae 6075
Bosea eneae 1719
Bosea vestrisii 1338
Acinetobacter beijerinckii 2236
Staphylococcus pasteuri 208 601
Rhodobacter blasticus 525
Frontiers in Microbiology | www.frontiersin.org 7 March 2020 | Volume 11 | Article 415
fmicb-11-00415 March 24, 2020 Time: 11:42 # 8
Stinson et al. Bacterial Profiles in Mid-Trimester AF
FIGURE 3 | Percent abundance (highest to lowest) of bacterial species in all mid-trimester amniotic fluid samples (n = 27).
TM7). Six samples contained reads that mapped to A. temperans
with a reasonably good level of sequence homology (98.3%).
A. temperans is a Gram-negative rod with mega-pili on its
surface, and has previously been isolated from various clinical
and environmental samples, including urine, cervical swabs, and
wastewater (Willems et al., 1990). This species has not previously
been identified in amniotic fluid. Four samples contained reads
that mapped to T. taiwanensis with 97.2% sequence homology.
T. taiwanensis is a relatively uncharacterized bacteria that was
first described in 2006 in hot springs (Chen et al., 2006). It
is a Gram-negative, motile rod with a single polar flagellum.
Given that T. taiwanensis is a thermophile found at moderately
high temperatures (50–60◦C), it is unlikely to be the correct
identity for this particular OTU. Although the sequence matched
reasonably well to this particular bacterium, a 2.8% difference
in a 1.5 kb amplicon represents a 42 bp difference in the 16S
rRNA gene. It is, therefore, possible that this OTU belongs
to an as yet uncharacterized bacterium. This sequence was
not detected in any of the negative controls. Four samples
contained reads that mapped to P. puraquae with a high level
of sequence homology (99.5%). P. puraquae is a relatively
uncharacterized bacteria, first isolated in 2007 from hemodialysis
water (Gomila et al., 2007), and previously reported in amniotic
fluid samples collected during cesarean section (Stinson et al.,
2019a) and in endometrial samples (Fang et al., 2016; Verstraelen
et al., 2016). It is a Gram-negative, motile rod with a single
polar flagellum. Although P. puraquae is often thought of as
a contaminant in microbiome research (Salter et al., 2014), it
was present in only one of the eight ECs taken here and in
neither of the two PCR controls. The ECs processed in the
same batch as the samples that contained reads mapping to
P. puraquae did not contain reads mapping to P. puraquae
themselves. Although this species has not previously been
identified in mid-trimester amniotic fluid samples, Urushiyama
et al. (2017) reported finding reads that mapped to Pelomonas
saccharophila in mid-trimester amniotic fluid samples using short
read sequencing.
Other less abundant OTUs identified here are in line with
those previously documented in mid-trimester amniotic fluid
samples by others. Four of our samples contained reads that
mapped to Propionibacterium acnes, which has previously been
identified in mid-trimester amniotic fluid (Urushiyama et al.,
2017; Zhu et al., 2018) as well as in amniotic fluid at term (Collado
et al., 2016; Stinson et al., 2019a). We also identified reads
that mapped to Bacillus sp. (which could not be differentiated
between Bacillus anthracis, Bacillus cereus, Bacillus mycoides,
Bacillus pseudomycoides, Bacillus thuringiensis, and Bacillus
weihenstephanensis) and Bacillus niabensis. Reads that map to
species of the Bacillus genus have been consistently reported in
previous studies of the mid-trimester amniotic fluid microbiome
(Urushiyama et al., 2017; Kayem et al., 2018; Zhu et al.,
2018). Other genera detected here that have also been detected
using short sequence technology in mid-trimester amniotic fluid
include Arthrobacter sp., Streptococcus sp., Staphylococcus sp.,
Massilia sp., and Paenibacillus sp. (Urushiyama et al., 2017;
Kayem et al., 2018; Zhu et al., 2018). Interestingly, bacterial
species typically associated with ascending intrauterine infection
and preterm labor were not detected in this study (Keelan et al.,
2016). This supports the view that invasion by such species
represents a pathological event that likely occurs after 20 weeks’
gestation, whereas potential colonization by the species identified
in this study occurs much earlier and is non-pathogenic.
Comparison of Mid-Trimester Bacterial
DNA Profiles From Term and Preterm
Pregnancies
We were unable to identify any significant differences in bacterial
DNA profiles of amniotic fluid from women with a spontaneous
PTD or a delivery at term. There was no difference in alpha
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diversity of cases and controls (number of observed OTUs
p = 0.87; Chao1 p = 0.44) (Figure 4). Nor was there any difference
in beta diversity of cases and controls (PERMANOVA p = 0.534).
None of the species detected here varied in abundance between
cases and controls upon univariate analysis.
We may have been unable to identify any predictive bacterial
DNA signatures for spontaneous PTD due to the gestational age
at which these samples were taken. Spontaneous PTD-associated
bacteria have previously been detected in amniotic fluid samples
early in gestation [Ureaplasma spp. at 20 weeks (Han et al., 2009;
Romero et al., 2014), Fusobacterium spp. at 21 weeks (Han et al.,
2009), and U. parvum, Citrobacter koseri and viridans group
streptococcus at 22 weeks (Han et al., 2009; Romero et al., 2014)],
but not prior to 20 weeks. The average gestational age at which
the present samples were taken was 15+6 weeks. It may have
been more informative for our purposes to collect amniotic fluid
samples later in the second trimester; however, amniocentesis is
not routinely performed at this stage of pregnancy, making such
a study unfeasible. Further, ours was a cohort of asymptomatic
women presenting for genetic amniocentesis, while previous
detection of early pathogenic colonization of amniotic fluid has
occurred in women presenting with spontaneous preterm labor
and preterm rupture of membranes.
Previously, Urushiyama et al. (2017) profiled amniotic fluid
samples obtained during cesarean section from pregnancies
with various stages of chorioamnionitis. As well as identifying
pathogenic bacteria in cases of high grade chorioamnionitis,
these authors also found an inverse relationship between
alpha diversity and chorioamnionitis severity. This might
suggest that amniotic fluid with a low diversity of bacteria
is more vulnerable to infection than amniotic fluid with a
high diversity of bacteria. Conversely, these data might also
suggest that intra-amniotic infection with pathogenic bacteria
reduces amniotic fluid diversity. Their data therefore poses
a chicken or the egg question: Does low diversity precede
infection, or does infection result in low diversity? We did
FIGURE 4 | Alpha diversity (number of observed operational taxonomic units)
in cases (n = 9) and controls (n = 18).
not find any differences in the alpha diversity of amniotic
fluid samples from women with a spontaneous PTD compared
to women with a term delivery. However, given the low
number of spontaneous PTD in our cohort and the lack
of data on placental pathology, we are unable to clarify
this question here.
Contribution to the “Sterile Womb”
Debate
The idea that the womb is sterile continues to be hotly debated
in both scientific and lay circles. The data presented here at
the very least support the notion that exposure to bacterial
DNA may occur prior to birth in some healthy pregnancies.
Further, we have provided evidence that this exposure occurs
early in pregnancy. Although we do not know if this DNA
is representative of live, biologically active cells, due to our
carefully controlled processing protocols, it is unlikely to be
cell-free bacterial DNA. However, questions remain around the
interpretation of such data. Low biomass samples are notoriously
difficult to accurately characterize, and the interpretation of
data from these environments must be performed cautiously
(Stinson et al., 2019b). As in all other microbiome studies,
there is also always a risk of contamination. Although we have
used rigorous experimental controls and decontaminated PCR
reagents, it should be kept in mind that we did not include
any negative controls during sampling. Further, the observed
bacterial signatures in these samples do not necessarily imply
the presence of a true “microbiome” (that is, an ecological
system of interacting organisms and their environment). Our
results might reflect the presence of bacteria that are transferred
from mother to fetus, but are not suited to survive within
the womb. These bacteria may therefore be transiently present,
but not true colonizers. Indeed, this may explain the low
abundance of bacteria in our samples. If a true microbiome
was established this early in pregnancy, we might expect it to
become increasingly abundant after months of incubation in
utero. However, data from other studies of the amniotic fluid
microbiome suggest that it remains low abundance at term
(Collado et al., 2016; Urushiyama et al., 2017; Stinson et al.,
2019a). Another explanation for the low titer of bacteria found
within the intra-amniotic space is the presence of both fetal and
maternal immunological components in amniotic fluid which
may suppress bacterial growth [for instance maternal and fetal
neutrophils (Gomez-Lopez et al., 2017)]. Alternatively, non-
bacterial microbial elements such as bacteriophages may curate
bacterial communities in utero and prevent them from expanding
in biomass; a previous study has already reported that nearly all
reads associated with viruses in amniotic fluid were associated
with bacteriophages (Lim et al., 2018).
CONCLUSION
Here we have provided evidence that, while most mid-trimester
amniotic fluid samples are sterile, bacterial DNA is present in
amniotic fluid at this time point in approximately one in five
pregnancies. Mid-trimester amniotic fluid bacterial DNA profiles
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are of low biomass and low diversity. We were not able to identify
any differences in the bacterial DNA profiles of samples from
pregnancies that had a spontaneous PTD and matched term
controls. The developmental and immunological significance
of the presence or absence of bacterial DNA in mid-trimester
amniotic fluid samples remains unclear.
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